Skip to navigation Skip to content Skip to subnav
Searching 2021-2022 Session

2021-2022 Session

Change Session
Select a session

S.22 (Act 61)

An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Sen. Virginia Lyons , Sen. Richard McCormack
5/21/2021 - Senate Message, signed by Governor June 7, 2021
Sponsor(s)
Last Recorded Action
House 5/21/2021 - Senate Message, signed by Governor June 7, 2021
Bill/Resolution Text

NOTE: to print information that appears on a tab within the bill page, use the Print link on that tab.

An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Detailed Status

Regular Session 2021-2022
Body Date Journal Calendar Location Full Status
An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Roll Call History

Regular Session 2021-2022
Body Date Journal Location Full Status

Back to top

Although procedurally bills and resolutions are assigned to only one committee at a time, other committees may review the bill or resolution. This page contains results from both the assigned committee as well as other committees.

An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Committee Meetings

Regular Session 2021-2022
Meeting Date Committee
An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Meeting Full List

Regular Session 2021-2022
Wednesday, January 27, 2021
Committee(s):
Senate Committee on Health and Welfare
-

S.22 - An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Introduction, walk through

Sen. Virginia "Ginny" Lyons, Sponsor, Chittenden County
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel

Wednesday, February 10, 2021
Committee(s):
Senate Committee on Health and Welfare
11:00 AM

S.22 - An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Walk-through, committee discussion

Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel

Friday, February 19, 2021
Committee(s):
Senate Committee on Health and Welfare
9:00 AM

S.22 - An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Testimony

Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
Daniel Weiss, Professor of Medicine, Professor of Cell and Molecular Biology, University of Vermont
Cindy Bruzzese, Executive Director & Clinical Ethicist, Vermont Ethics Network
David Herlihy, Executive Director, Vermont Board of Medical Practice
Jill Abrams, Assistant Attorney General, Director, Consumer Protection Division, Attorney General's Office
Jessa Barnard, Executive Director, Vermont Medical Society

Tuesday, February 23, 2021
Committee(s):
Senate Committee on Health and Welfare
10:10 AM

S.22 - An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Committee discussion

Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel

Friday, February 26, 2021
Committee(s):
Senate Committee on Health and Welfare
9:30 AM

S.22 - An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Committee discussion, vote

Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel

Friday, March 19, 2021
Committee(s):
House Committee on Health Care
1:30 PM

S.22 - An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Walk-through

Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel

Wednesday, April 7, 2021
Committee(s):
House Committee on Health Care
10:00 AM

S.22 - An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Sen. Cheryl Hooker, Reporter, Senate Health and Welfare
Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
Daniel Weiss, Professor of Medicine, Professor of Cell and Molecular Biology, University of Vermont
David Herlihy, Executive Director, Vermont Board of Medical Practice
Jessa Barnard, Executive Director, Vermont Medical Society
Cindy Bruzzese, Executive Director & Clinical Ethicist, Vermont Ethics Network
Jill Abrams, Assistant Attorney General, Director, Consumer Protection Division, Attorney General's Office

Wednesday, April 28, 2021
Committee(s):
House Committee on Health Care
9:00 AM

S.22 - An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Committee discussion

Sam Russo, Vermont Association of Naturopathic Physicians
Lauren Hibbert, Director, Office of Professional Regulation, Secretary of State's Office

Friday, April 30, 2021
Committee(s):
House Committee on Health Care
10:50 AM

S.22 - An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Vote


An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Witnesses Who Testified

Regular Session 2021-2022
House Committee on Health Care
  • Jill Abrams, Assistant Attorney General, Director, Consumer Protection Division, Attorney General's Office
  • Jessa Barnard, Executive Director, Vermont Medical Society
  • Cindy Bruzzese, Executive Director & Clinical Ethicist, Vermont Ethics Network
  • Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
  • David Herlihy, Executive Director, Vermont Board of Medical Practice
  • Lauren Hibbert, Director, Office of Professional Regulation, Secretary of State's Office
  • Sen. Cheryl Hooker, Reporter, Senate Health and Welfare
  • Sam Russo, Vermont Association of Naturopathic Physicians
  • Daniel Weiss, Professor of Medicine, Professor of Cell and Molecular Biology, University of Vermont
Senate Committee on Health and Welfare
  • Jill Abrams, Assistant Attorney General, Director, Consumer Protection Division, Attorney General's Office
  • Jessa Barnard, Executive Director, Vermont Medical Society
  • Cindy Bruzzese, Executive Director & Clinical Ethicist, Vermont Ethics Network
  • Jennifer Carbee, Deputy Chief Counsel, Office of Legislative Counsel
  • David Herlihy, Executive Director, Vermont Board of Medical Practice
  • Sen. Virginia "Ginny" Lyons, Sponsor, Chittenden County
  • Daniel Weiss, Professor of Medicine, Professor of Cell and Molecular Biology, University of Vermont

Back to top

Fiscal notes and materials available on this web page are provided for informational purposes only, and may not comprise all materials received by the Vermont Legislature or the final fiscal information related to a specific bill.  The Legislature is not responsible for the accuracy of any information in these materials, and their posting does not constitute approval or endorsement by the Legislature.

No fiscal documents found for S.22 in the Regular Session 2021-2022.
No committee of conference members found for S.22 in the Regular Session 2021-2022.
An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Committee of Conference Meetings

Regular Session 2021-2022
Meeting Date Committee
An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Committee of Conference Meeting Full List

Regular Session 2021-2022
No committee of conference meeting history found for S.22 in the Regular Session 2021-2022.
No committee of conference report found for S.22 in the Regular Session 2021-2022.

Back to top

Act


An act relating to health care practitioners administering stem cell products not approved by the U.S. Food and Drug Administration

Statutes Affected

Regular Session 2021-2022

Back to top

Staff & Other Information

Staff
Jennifer Carbee, Deputy Chief Counsel

Back to top